Stay updated on Pembrolizumab in SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in SCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:08:43.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains blocked by a 403 error, with the displayed site revision updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T01:14:51.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page content has shifted from detailed study information to an access-restricted 403 error, with a standard site header/footer visible and an explicit 403 message, effectively rendering the study information unavailable.
    Difference
    20%
    Check dated 2026-09-23T01:15:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s internal version was updated to v3.7.0, indicating a maintenance update to the site’s infrastructure. This change does not modify the study text or visible information on the page.
    Difference
    0.1%
    Check dated 2026-09-16T00:25:18.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label at the bottom of the page was updated from v3.6.5 to v3.6.6. This indicates a minor site or template update, with no changes to the study details displayed.
    Difference
    0.1%
    Check dated 2026-09-01T20:38:46.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page now displays a newer revision label, v3.6.5, replacing the previous v3.6.4, indicating a small maintenance update to the page's metadata. This change does not alter the study details or content presented on the page.
    Difference
    0.1%
    Check dated 2026-08-11T13:16:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.